TerrAscend (CSE:TER,OTCQX:TRSSF) announced its manufacturing facility in Mississauga, Ontario secured its Good Manufacturing Practice (GMP) certificate based on rules governing medicinal products in the European Union (EU).
As quoted in the press release:
The EU GMP certification was awarded by the responsible agency, Arzneimittelbehörde, in North Rhine-Westphalia, Germany. Additionally, the Company has entered a comprehensive sales and distribution agreement with iuvo Therapeutics GmbH (iuvo), a German pharmaceutical wholesaler with a cannabis-specific import and distribution license. TerrAscend expects to begin distribution through iuvo this quarter.
EU GMP standards for pharmaceuticals are among the most rigorous in the world, demanding the highest levels of quality assurance and product consistency. Following a pre-audit review by Cannabis Compliance Inc., a comprehensive inspection was conducted over a [four]-day period by government officials from the responsible agency at the Company’s 67,300 [square feet] facility in Mississauga.